The data forecasts the re-import of vaccines for human use to the UK to rise steadily from 2024 to 2028, with values starting at 9.89 thousand kilograms in 2024 and reaching 11.62 thousand kilograms by 2028. As of 2023, this value stood lower, suggesting a positive upward trend over this period. The projected year-on-year increase from 2024 through 2028 implies consistent growth, indicative of increased demand or resourcing.

Future trends to watch include:

Potential shifts in global vaccine supply chains that could influence import patterns.
Policy changes in the UK related to healthcare and pharmaceuticals that might affect import dynamics.
Technological advancements in vaccine production that could impact importing needs.